Lyxumia

lixisenatide · Sanofi

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Lyxumia, covering 2015-01-22 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes